Early research (Phase 1)Looking for participantsNCT03816345
What this trial is testing
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Who this might be right for
Autoimmune DiseaseCrohn DiseaseDermatomyositis+11 more
National Cancer Institute (NCI) 300